Portal Hypertension and Liver Disease
Portal hypertension is increased pressure in the portal venous system, most often due to cirrhosis. It is the driving force behind many decompensation events in advanced liver disease, including variceal bleeding, ascites, and hepatic encephalopathy.
What Is Portal Hypertension?
Portal hypertension means the pressure in the portal venous system is abnormally high, usually defined by a hepatic venous pressure gradient (HVPG) greater than 5 mm Hg, with “clinically significant portal hypertension” (CSPH) at ≥10–12 mm Hg.
- The portal vein drains blood from the stomach, intestines, pancreas, and spleen into the liver, where toxins are filtered and nutrients are processed.
- When resistance to flow through the liver increases (for example, from cirrhosis and scarring), pressure in the portal system rises and blood looks for “detours” through collateral veins.
- These collaterals can enlarge into esophageal and gastric varices, rectal varices, and abdominal wall veins, and they can bleed.
For patients with cirrhosis, portal hypertension is often the dividing line between compensated and decompensated disease and is a major driver of transplant evaluation.
Causes and Types of Portal Hypertension
Causes are often classified as prehepatic, intrahepatic, or posthepatic, depending on where along the portal circulation the obstruction occurs.
Intrahepatic (most common)
- Cirrhosis from alcohol use disorder, chronic viral hepatitis, or metabolic-associated fatty liver disease.
- Autoimmune and cholestatic disease (autoimmune hepatitis, primary biliary cholangitis, PSC).
- Infiltrative or fibrotic disorders (congenital hepatic fibrosis, nodular regenerative hyperplasia).
Prehepatic
- Portal vein thrombosis or stenosis.
- Splenic vein thrombosis with large collateral flow.
- Congenital portal venous malformations.
Posthepatic
- Budd–Chiari syndrome (hepatic vein thrombosis).
- Right-sided heart failure or constrictive pericarditis.
- Severe veno-occlusive disease or sinusoidal obstruction syndrome.
Cirrhotic vs. noncirrhotic portal hypertension
- Cirrhotic portal hypertension is by far the most common in transplant candidates and is driven by both structural (fibrosis, nodules) and dynamic (vasoactive) changes in the liver.
- Noncirrhotic portal hypertension can occur with a relatively preserved liver architecture; patients may still have large varices and splenomegaly yet near-normal synthetic function.
Major Complications of Portal Hypertension
Many of the feared complications of advanced liver disease are direct consequences of portal hypertension.
Varices and variceal hemorrhage
- Esophageal and gastric varices form when high portal pressure redirects blood through submucosal veins in the esophagus and stomach.
- Once portal pressure exceeds roughly 12 mm Hg, varices are at risk for rupture and life-threatening upper GI bleeding.
Ascites and spontaneous bacterial peritonitis (SBP)
- Splanchnic vasodilation, renal sodium retention, and low oncotic pressure from hypoalbuminemia lead to accumulation of free fluid in the peritoneal cavity.
- Ascitic fluid is prone to infection (SBP), which can precipitate renal failure and death.
Hepatic encephalopathy
- Portosystemic shunting allows nitrogen-containing toxins (such as ammonia) to bypass the liver, leading to cognitive slowing, confusion, and in severe cases coma.
Other complications
- Hypersplenism with thrombocytopenia and leukopenia.
- Hepatorenal syndrome from severe circulatory dysfunction.
- Portal hypertensive gastropathy and colopathy causing chronic blood loss.
Evaluation and Screening
In practice, portal hypertension is usually diagnosed clinically rather than by direct pressure measurement, but the HVPG remains the gold standard in research and specialized centers.
Noninvasive clues
- Stigmata of chronic liver disease with splenomegaly and thrombocytopenia.
- Ultrasound or Doppler showing a dilated portal vein, decreased portal flow, or collaterals.
- Presence of ascites, varices, or portosystemic collaterals on imaging.
Upper endoscopy
- Standard of care for detecting esophageal and gastric varices in patients at risk, although recent guidance incorporates noninvasive criteria to defer endoscopy in low-risk patients.
Hepatic venous pressure gradient (HVPG)
- Measured via a transjugular catheter; HVPG ≥10–12 mm Hg defines clinically significant portal hypertension in most studies.
- Used to stratify risk, follow response to therapy (for example, nonselective beta-blockers), and in some centers to guide timing of TIPS or transplant evaluation.
Treatment and Prevention Strategies
Management focuses on lowering portal pressure, preventing first decompensation, and treating complications such as variceal bleeding and refractory ascites.
Medical therapy
- Nonselective beta-blockers (propranolol, nadolol, carvedilol) reduce portal pressure and lower the risk of first variceal bleed and other portal-hypertensive events in many patients.
- Vasoactive drugs (terlipressin, octreotide, somatostatin) are used during acute variceal hemorrhage together with endoscopic band ligation.
- Diuretics and salt restriction are used for ascites; albumin and antibiotics are added for SBP.
Endoscopic therapy
- Endoscopic variceal ligation (EVL) is the mainstay for treating and preventing variceal bleeding.
- For gastric varices, cyanoacrylate injection or other specialized techniques may be required.
TIPS and other shunts
- A transjugular intrahepatic portosystemic shunt (TIPS) creates a tract between the portal and hepatic veins to decompress the portal system in selected patients.
- Indications include uncontrolled or recurrent variceal bleeding and refractory ascites in appropriate candidates; it may also be used pre-emptively in high-risk bleeding.
- Risks include hepatic encephalopathy and, in some cases, worsening heart failure or liver function; careful patient selection and multidisciplinary discussion are essential.
Definitive therapy
- Because portal hypertension in cirrhosis reflects advanced structural liver disease, liver transplantation is the only definitive cure for most cirrhotic portal hypertension.
Portal Hypertension and Liver Transplant Evaluation
Portal hypertension is central to transplant decision-making because it is closely linked to decompensation, quality of life, and survival.
- First decompensating events such as variceal hemorrhage, recurrent ascites, or hepatic encephalopathy often trigger a referral for transplant evaluation.
- HVPG and noninvasive markers of CSPH can help risk-stratify compensated patients, even before MELD scores become very high.
- TIPS may be used as a “bridge to transplant” in selected patients with difficult-to-control bleeding or ascites, but it does not replace the need for transplant when liver failure progresses.
- For patients and families, understanding portal hypertension can make sense of why “sudden” events like bleeding or confusion occur and why the team may recommend transplant even if labs appear acceptable on paper.
Selected References
- Mazumder NR, et al. A practical guide to portal hypertension: pathophysiology, diagnosis, and management. Clin Liver Dis. 2025.
- Kaplan DE, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2024.
- Simonetto DA, et al. Portal hypertension and related complications: diagnosis and management. Mayo Clin Proc. 2019.
- Gunarathne LS, et al. Cirrhotic portal hypertension: from pathophysiology to novel therapeutics. World J Gastroenterol. 2020.
- Oliver TI, et al. Portal Hypertension. StatPearls [Internet]. 2023.
- Cleveland Clinic. Portal Hypertension: Symptoms and Treatment. Patient summary page.
- Merck Manual Professional Edition. Portal Hypertension. MerckManuals.com. 2024.
- AASLD. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Guidance. AASLD Practice Guidance.
Medical Disclaimer
This page is for education only. It cannot replace individualized advice from your hepatologist or transplant team. If you have cirrhosis, portal hypertension, or related complications, decisions about screening, medications, TIPS, or liver transplantation must be made with your own clinicians based on your complete medical history and current condition.